Harbour Investments’s Invesco Pharmaceuticals ETF PJP Stock Holding History
Bought
Maintained
Sold
Other funds holding PJP
PAM
JGCM
Harbour Investments's PJP Position: Q2 2026 in Review
Harbour Investments increased its Invesco Pharmaceuticals ETF (PJP) stake by 1.9% in Q2 2026, buying an estimated $3.68K and bringing the position to 1,803 shares worth $214K. The position accounts for ﹤0.01% of the portfolio, ranked #1570.
Harbour Investments first reported a position in PJP in Q1 2021 and has held it in 21 quarters since. 117 funds tracked by Wall St. Rank hold PJP as of Q2 2026.
- Harbour Investments held 1,803 shares of Invesco Pharmaceuticals ETF worth $214K as of Q2 2026.
- Harbour Investments bought 34 Invesco Pharmaceuticals ETF shares in Q2 2026, an estimated $3.68K.
- Invesco Pharmaceuticals ETF made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #1570 holding.
- Harbour Investments first reported a position in Invesco Pharmaceuticals ETF in Q1 2021 and has held it in 21 quarters since.
- 117 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.
Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.